- Exchange: Tokyo
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Takeda Pharmaceutical Co Ltd
+ Add to Watchlist4502:JP
4,745 JPY 55 1.15%As of 02:00:00 ET on 05/24/2013.
Snapshot for Takeda Pharmaceutical Co Ltd (4502)
| Open: | 4,800 | Day's Range: | 4,570 - 4,875 | Volume: | 6,904,300 |
|---|---|---|---|---|---|
| Previous Close: | 4,745 | 52wk Range: | 3,235 - 5,520 | 1-Yr Rtn: | +49.95% |
Key Statistics for 4502
| Current P/E Ratio (ttm) | 28.5419 |
|---|---|
| Estimated P/E(03/2014) | 23.7809 |
| Relative P/E vs. TPX | 1.2303 |
| Earnings Per Share (JPY) (ttm) | 166.2470 |
| Est. EPS (JPY) (03/2014) | 199.5300 |
| Est. PEG Ratio | 2.1678 |
| Market Cap (M JPY) | 3,746,965.50 |
| Shares Outstanding (M) | 789.67 |
| 30 Day Average Volume | 4,154,003 |
| Price/Book (mrq) | 1.7343 |
| Price/Sale (ttm) | 2.4054 |
| Dividend Indicated Gross Yield | 3.79% |
| Cash Dividend (JPY) | 90.0000 |
| Last Dividend | 09/26/2013 |
| 5 Year Dividend Growth | 1.39% |
| Next Earnings Announcement | 07/30/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for 4502
Company Profile & Key Executives for 4502
Takeda Pharmaceutical Company Limited mainly manufactures and sells pharmaceuticals, food supplements, and chemical products like polyurethane. The Company also produces food, agrochemicals, and environment-related products such as pollution detectors. Takeda Pharmaceutical researches, develops, and promotes the products through its related companies in the US, Europe, and Asia.
| Yasuchika HasegawaPresident/CEO | Toyoji YoshidaManaging Director/CAO |
| Yasuhiko YamanakaManaging Director | Frank MorichDirector |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
4502 News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page